NCT07035249: DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 9 planned
- Started
- 16 Dec 2025
- Primary completion
- 1 Jun 2027
- Arms
- Low Dose
- Results
- None posted
- 25 Jun 2025: Trial registered
- 16 Dec 2025: Trial started